Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-09-003278

Options or other derivatives

  • Interim CEO acquired 2,503,858 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chan Phillip P. · Interim CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2009-01-08 Grant or award : show line 1 in the form Stock Option +2,503,858 2,518,858 D
Loading xslF345X03/v137358_ex.xml…